An update on Superbugs in 2016 – Agenda released to tackle the threat of anti-microbial resistance

SMi Group is thrilled to announce that agenda has now been released for the 18th annual conference on Superbugs & Superdrugs, set to take place on 16th and 17th March 2016 in London, UK
By: SMi Group
 
 
Superbugs & Superdrugs 2016
Superbugs & Superdrugs 2016
LONDON - Nov. 4, 2015 - PRLog -- SMi is thrilled to introduce the 18th annual conference on Superbugs & Superdrugs, taking place on 16th and 17th March 2016 in London, UK.

Expanding horizons on the growing global threat of anti-microbial resistance for almost two decades, Superbugs & Superdrugs will once again play host to an international audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to discuss the latest clinical advancements and funding opportunities.

Working with an expert advisory board and an esteemed panel of industry leaders, the new agenda for 2016 will hone in on key topics such as R&D, collaboration, global epidemics, monoclonal anti-bodies, genome sequencing, rapid diagnostic tools, antibiotic alternatives, multi-resistance gram-negative infections, resistance prevention, antimicrobial peptides, combination therapies, microbiodata host interactions, plus much more!

Featured Speakers Include:

Richard Bax, Senior Partner, Transcrip Partners
Lloyd Czaplewski, Director, Chemical Biology Ventures Ltd
Line Matthiessen, MD PhD, Head of Unit Fighting Infectious Diseases and Advancing Public Health, European Commission
Melissa Stundick, Chief, Anti-Infectives Programme, BARDA
Ursula Theuretzbacher, Founder, Centre for Anti-Infective Agents
Prabhavathi Fernandes, President & CEO, Cempra Pharmaceuticals
Ankit Mahadevia, MD , President & CEO, Spero Therapeutics
Eszter Nagy, Co-founder, President and CSO, Arsanis
Jean de Gunzburg, Chief Scientific Officer, Da Volterra
David Cook, Chief Scientific Officer, Blueberry Therapeutics
Conrad Lichtenstein, Chief Scientific Officer, Nemesis Bioscience
Steven Boakes, Associate Director of Microbiology, Cantab Anti-Infectives

The conference will aim to:

1. Provide networking opportunities with industry-leading experts on drug and antimicrobial material developments
2. Present new funding opportunities from BARDA to combat antimicrobial resistance
3. Discuss how the EU Commission's practical approach in R&D can support business growth
4. Look to reinvigorate business models with Project DRIVE-AB and find workable solutions to strengthen drug development
5. Build antibiotic pipelines with new insights on microbiome profiling to fight multi-resistant gram negative infections
6. Tackle major bottlenecks that hinder development of new antimicrobial drugs through interactive debate

Further details can be found on the website at https://www.smi-online.co.uk/pharmaceuticals/uk/superbugs...

For those who are interested in attending, a £400 early bird saving is currently available online which expires on November 30th.

18th annual conference: Superbugs & Superdrugs
16-17 March 2016
Holiday Inn Kensington Forum, London UK
https://www.smi-online.co.uk/pharmaceuticals/uk/superbugs-superdrugs

--- END ---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Antibiotic, Superbug, Infectious Disease
Industry:Medical
Location:London - England - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share